<DOC>
	<DOCNO>NCT00002283</DOCNO>
	<brief_summary>Evaluate effectiveness rate dapsone plus trimethoprim therapy first episode Pneumocystis carinii pneumonia ( PCP ) AIDS patient . Compare rate severity adverse effect use dapsone versus trimethoprim - sulfamethoxazole ( TMP / PurposeX ) . Establish relative toxicity regard suitability outpatient treatment .</brief_summary>
	<brief_title>A Comparison Dapsone Trimethoprim-Sulfamethoxazole Treatment Pneumocystis Carinii Pneumonia ( PCP ) Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Exclusion Criteria Concurrent Medication : Excluded : Requirement medication find effective treatment Pneumocystis carinii pneumonia ( PCP ) ( i.e. , DFMO , pyrimethamine , sulfadiazine ) . Patients follow exclude : History allergic reaction dapsone . Requirement medication find effective treatment Pneumocystis carinii pneumonia ( PCP ) ( i.e. , DFMO , pyrimethamine , sulfadiazine ) . Patients subsequently find glucose6phosphate dehydrogenase ( G6PD ) positive withdrawn study treat another regimen . Prior Medication : Excluded : Requirement medication find effective treatment Pneumocystis carinii pneumonia ( PCP ) ( i.e. , DFMO , pyrimethamine , sulfadiazine ) . Patients glucose6phosphate dehydrogenase ( G6PD ) positive withdrawn study treat another regimen . Hospitalized patient first episode Pneumocystis carinii pneumonia ( PCP ) document GIEMSA methenamine stain . Patients must : Be willing able give inform consent . Be expect survive 1 week without therapy . Have less 48 hour treatment Pneumocystis carinii pneumonia ( PCP ) episode .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1989</verification_date>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Dapsone</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>